Search Results
Jun 29, 2026, 10:31 ET Nephrotic Syndrome Market Set for Robust Growth During the Forecast Period (2026-2036), Driven by Emerging Therapies and Expanding Research | DelveInsight
Pharmaceuticals, Boehringer Ingelheim, Roche, Kezar Life Sciences, Vera Therapeutics, Walden Biosciences, Aurinia Pharmaceuticals, Otsuka Pharmaceutical, GSK, Johnson & Johnson, Travere Therapeutics, CSL Vifor, Calliditas Therapeutics AB, and others
More news about: DelveInsight Business Research, LLP
Jun 26, 2026, 18:49 ET Axtria Ignite 2026 : plus de 450 dirigeants du secteur des sciences de la vie se réunissent pour lancer un message à contre-courant : « Renforcez les fondations avant de développer l'IA »
d'autres agents, commencez par consolider les basesLes Ignite Leadership Awards ont récompensé des dirigeants pionniers de Bristol Myers Squibb, GSK et Biogen ; le prix Axtria Bedrock Honor a salué un partenariat de 15 ans avec Quest DiagnosticsBERKELEY HEIGHTS,
More news about: Axtria, Inc.
Jun 26, 2026, 12:49 ET Axtria Ignite 2026: Über 450 Führungskräfte aus dem Life-Sciences-Bereich versammeln sich mit einer unkonventionellen Botschaft - Erst die Grundlagen schaffen, bevor man KI ausbaut
entwickelt, muss man zuerst die Grundlagen schaffenMit den Ignite Leadership Awards wurden Transformationsführer von Bristol Myers Squibb, GSK und Biogen geehrt; der Axtria Bedrock Honor würdigte eine 15-jährige Partnerschaft mit Quest DiagnosticsBERKELEY
More news about: Axtria, Inc.
Jun 26, 2026, 12:43 ET Axtria Ignite 2026：450名超のライフサイエンス業界リーダーが集結、AIを拡大展開する前に基盤整備を訴える型破りなメッセージを発信
Chadhaは、直感に反する方針を掲げて業界に課題を投げかけました。エージェントをさらに構築する前に、まず基盤を整備せよイグナイト・リーダーシップ・アワード（Ignite Leadership Awards）では、Bristol Myers Squibb、GSK、Biogenの変革リーダーが表彰されました。また、Axtriaベッドロック栄誉賞（Axtria Bedrock Honor）では、Quest Diagnosticsとの15年にわたるパートナーシップが称えられました。ニュージャージー州バークレー・ハイツ,
More news about: Axtria, Inc.
Jun 25, 2026, 13:56 ET Are NUVL, CPRX, TMHC Obtaining Fair Deals for their Shareholders?
Nuvalent, Inc. (NASDAQ: NUVL)'s sale to GSK plc for $124.00 per share in cash. If you are a Nuvalent shareholder,
More news about: Halper Sadeh LLP
Jun 25, 2026, 08:15 ET Axtria Ignite 2026: 450+ Life Sciences Leaders Convene With a Contrarian Message -- Fix the Foundation Before You Scale AI
before you build more agents, fix the foundation firstThe Ignite Leadership Awards honored transformation leaders from Bristol Myers Squibb, GSK, and Biogen; the Axtria Bedrock Honor recognized a 15-year partnership with Quest DiagnosticsBERKELEY HEIGHTS,
More news about: Axtria, Inc.
Jun 25, 2026, 08:15 ET Axtria Ignite 2026: 450+ Life Sciences Leaders Convene With a Contrarian Message -- Fix the Foundation Before You Scale AI
before you build more agents, fix the foundation firstThe Ignite Leadership Awards honored transformation leaders from Bristol Myers Squibb, GSK, and Biogen; the Axtria Bedrock Honor recognized a 15-year partnership with Quest DiagnosticsBERKELEY HEIGHTS,
More news about: Axtria, Inc.
Jun 24, 2026, 15:36 ET $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TMHC, NUVL, AXTA, and PFLC
NUVL) related to its sale to GSK plc. Under the terms of the proposed transaction, Nuvalent shareholders are expected to receive $124.00 per share in cash.ACT NOW. The
More news about: Monteverde & Associates PC
Jun 24, 2026, 09:21 ET EP3M Summit 2026 Brings Together Biopharma Leaders to Advance Portfolio Strategy, Decision Intelligence, and Innovation Portfolio Management
of the industry's leading organizations, including AbbVie, BeOne Medicines, Biogen, Bristol Myers Squibb, Eli Lilly and Company, Flagship Pioneering, GSK, Merck, Novartis, Sanofi, and UCB, . Key topics include strategic prioritization and portfolio value optimization, decision intelligence and portfolio
More news about: Cambridge Healthtech Institute
Jun 22, 2026, 17:07 ET Are ROKU, SLP, NUVL, DAN Obtaining Fair Deals for their Shareholders?
click here to learn more about your rights and options.Nuvalent, Inc. (NASDAQ: NUVL)'s sale to GSK plc for $124.00 per share in cash. If you are a Nuvalent shareholder,
More news about: Halper Sadeh LLP
Jun 19, 2026, 18:21 ET New 5W AI Visibility Index: Pharma Spends Billions on DTC Ads. The AI Engines Talk About Eli Lilly and Novo Nordisk Anyway
3.0%10. Novartis — Specialty & gene therapy — 2.6%11. Bristol Myers Squibb — Oncology & cardiovascular — 2.3%12. GSK — Vaccines & respiratory — 2.0%13. Sanofi — Immunology & vaccines — 1.8%14. Gilead Sciences — Antivirals &
More news about: 5W Public Relations
Jun 18, 2026, 11:28 ET Are NUVL, DAN, PAYO Obtaining Fair Deals for their Shareholders?
Nuvalent, Inc. (NASDAQ: NUVL)'s sale to GSK plc for $124.00 per share in cash. If you are a Nuvalent shareholder,
More news about: Halper Sadeh LLP
Jun 17, 2026, 13:50 ET $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SUNE, NUVL, CCRN, and BGMS
NUVL) related to its sale to GSK plc. Under the terms of the proposed transaction, Nuvalent shareholders are expected to receive $124.00 per share in cash.Click here
More news about: Monteverde & Associates PC
Jun 15, 2026, 12:31 ET EGFR Inhibitors Market to Witness Upsurge in Growth at a CAGR of 7.9% During the Forecast Period (2026-2036) Owing to the Entry of Next-generation TKIs, ADCs, and Combination Strategies with Immunotherapy| DelveInsight
Lilly and Company, Merck, Regeneron, Sanofi, Ono Pharmaceutical, Novartis, Genentech, Roche, Amgen, Chugai Laboratories, Moderna Therapeutics, Pfizer, GSK and others.
More news about: DelveInsight Business Research, LLP
Jun 15, 2026, 06:00 ET Halozyme Confirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Newly Released Draft Medicare Drug Price Negotiation Program Proposed Rule for IPAY 2029
Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical, Acumen Pharmaceuticals, Merus N.V., Skye Bioscience and GSK.Halozyme expanded its drug delivery technology portfolio to develop partner products using Hypercon™ and Surf Bio's hyperconcentration
More news about: Halozyme Therapeutics, Inc.
Jun 12, 2026, 12:00 ET Fleming Initiative and Cepheid Launch Landmark Study of Rapid Testing for Drug-Resistant Infections
10 Year Health Plan for England, and receives funding from industrial partners including GSK, LifeArc and Cepheid. The Initiative is working to deliver solutions ranging from novel diagnostic tests, AI-based drug discovery to public health campaigns,
More news about: Cepheid
Jun 12, 2026, 11:47 ET Are AVNS, NUVL, XOMA, TBRG Obtaining Fair Deals for their Shareholders?
click here to learn more about your rights and options.Nuvalent, Inc. (NASDAQ: NUVL)'s sale to GSK plc for $124.00 per share in cash. If you are a Nuvalent shareholder,
More news about: Halper Sadeh LLP
Jun 11, 2026, 12:39 ET Amedea Pharma, Inc. Announces Return of the Fifth Annual Medical Innovation Olympics at Rockefeller Center on June 12, 2026
and Sunovion Pharmaceuticals among others. Featured speakers have included pharma and biotech CEOs responsible for $2.5 billion R & D budget at GSK, now leading companies such as Epicrispr Bio (Amber Salzman), Longevity Medicine leaders such as James Peyer (CEO, Cambrian Biopharma), pioneers in aging
More news about: Amedea Pharma, Inc.
Jun 10, 2026, 12:20 ET Deerfield Management Announces Portfolio Company Nuvalent, Inc. to be Acquired by GSK
firm dedicated to advancing healthcare, today announced that portfolio company Nuvalent, Inc. has entered into a definitive agreement to be acquired by GSK for $10.6 billion.
More news about: Deerfield Management Company, L.P.
Jun 10, 2026, 10:52 ET The Franklin Institute and GSK Celebrate 40 Years of GSK Science in the Summer™ with New "Be A Chemist!" Theme and Program Expansion
their newly formed GSK STEM Holiday Clubs, helping to embed high-quality STEM programming for the long term."GSK Science in the Summer makes STEM exciting, giving students hands-on experience and career inspiration," said Becki Lynch, Head of Charitable Investments at GSK. "We're proud to
More news about: The Franklin Institute
Jun 10, 2026, 10:45 ET Shareholder Alert: Ademi LLP investigates whether Nuvalent, Inc. is obtaining a Fair Price for Public Shareholders
investigating Nuvalent (NASDAQ: NUVL) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with GSK plc.
More news about: Ademi LLP
Jun 09, 2026, 12:00 ET Perseus Information Security Consulting Becomes Fully Accredited Certification Body for ISASecure ACSSA Program
and supplier development practices since 2010.Founders and key supporters of ISASecure include BP, Chevron, ExxonMobil, Saudi Aramco, Shell, GSK, Honeywell, Johnson Controls, Schneider Electric, Yokogawa, Carrier, Siemens, YPF, Amazon Web Services, exida, TUV Rheinland, CSSC, FM Approvals, Synopsys,
More news about: The International Society of Automation
Jun 09, 2026, 10:01 ET Alcohol-associated Liver Disease Market Gearing Up for Outstanding Expansion at a CAGR of 31.1% During the Forecast Period (2026-2036) | DelveInsight
increasing emphasis on targeted, mechanism-based treatment approaches. Additionally, the anticipated emergence of mid-stage therapies such as GSK4532990 (GSK), INT-787 [Alphasigma (Intercept Pharmaceuticals)], and Pemvidutide (Altimmune) is likely to heighten competition within the ALD treatment landscape
More news about: DelveInsight Business Research, LLP
Jun 09, 2026, 09:00 ET Sedai Launches the First Autonomous Platform for AI Agent Optimization
The platform deploys with minimal disruption to existing code and integrates directly with the tools engineering teams already use. Organizations like GSK, KnowBe4, and Informed are already using Sedai to optimize their AI agent strategy.The release includes:Governance:
More news about: Sedai
Jun 05, 2026, 04:54 ET Le Sommet Veeva présente Falcon et l'avenir de la biopharmacie agentique
Plus de 2 000 personnes se sont réunies pour découvrir l'avenir de l'IA dans l'industrie AOP Health, Boehringer Ingelheim, GSK, Haleon, MSD, Novo Nordisk, Roche, Sanofi et Sobi figurent parmi les leaders qui partagent leurs stratégies afin de rationaliser et connecter leurs opérations
More news about: Veeva Systems